<DOC>
	<DOCNO>NCT02518464</DOCNO>
	<brief_summary>This prospective , open-label , single-arm pilot study treat 40 subject assess hypothesis P2Y , G protein-coupled 12 ( P2Y12 ) inhibition Brilinta/ticagrelor ( 90 mg PO twice day ) reduce episodic and/or chronic migraine headache symptom patient right leave shunt . Headache frequency Brilinta/ticagrelor compare document baseline subject . If Brilinta/ticagrelor therapy effective ( &gt; 50 % reduction monthly headache day ) , subject could elect continue therapy additional two month ( 56 day ) , continue complete daily headache log .</brief_summary>
	<brief_title>Ticagrelor Therapy RefrACTORy Migraine Study</brief_title>
	<detailed_description>Migraine headache poorly understood , severely debilitate . Many type drug try migraine sufferer include anti-depressants , anti-seizure medication , blood pressure medicine others . The investigator show small number patient , certain type blood thinner ( Clopidogrel ) reduce eliminate migraine headache patient also hole heart wall allow flow right side heart leave . Ticagrelor blood thin drug work way clopidogrel , break body differently thus allow everyone use . The investigator wish test medication see work well , good clopidogrel .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>At least one year history Episodic Chronic migraine headache symptom At least 6 headache day per month Subject able complete online daily headache log Inability understand study history noncompliance medical advice Currently take P2Y12 inhibitor Known hypersensitivity Brilinta/ticagrelor History stroke/transient ischemic attack ( TIA ) previous 6 month Active bleed site Active peptic ulcer disease upper gastrointestinal ( GI ) bleed within six ( 6 ) month Migraine onset 50 year age Renal impairment : Creatinine Clearance &lt; 60 cc/min Severe hepatic impairment total bilirubin &gt; 3.0 mg/dL Thrombocytopenia platelet count &lt; 100,000 / ul History intracranial hemorrhage Contraindications blood thinner therapy history major bleed episode take blood thinner therapy Need chronic oral anticoagulation therapy ( i.e . Atrial Fibrillation ) Need chronic antiplatelet therapy ( i.e . drugeluting ( DE ) Stent ) , include daily aspirin use Need daily nonsteroidal antiinflammatory drug ( NSAID ) use Need daily carbamazepine therapy strong CYP3A inhibitor potent CYP3A inducer Need simvastatin lovastatin great 40 mg daily Symptomatic bradycardia syncope Pregnancy currently breastfeed , plan become pregnant study period Planned surgery study timeframe Previously implant patent foramen ovale ( PFO ) , atrial septal defect ( ASD ) , pacemaker , inferior vena cava filter , leave atrial appendage closure device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>headache</keyword>
	<keyword>chronic</keyword>
	<keyword>migraine</keyword>
	<keyword>right leave shunt</keyword>
</DOC>